The proportion of tests resulting in a biopsy and/or diagnosis of PCa was compared with the programme of PSA testing, akin to screening, in the Prostate Testing for Cancer and Treatment (ProtecT) study17 to gauge whether PSA tests undertaken in UK GP can be considered as an effective attempt at screening. The gene discussed is KLK3; the disease is posterior cortical atrophy.